Our search demonstrated that the PTGS2 protein levels in breast cancer patients’ samples (Figure 4A, left & right panels) revealed positive staining (medium to high intensity) in 70% of the examined tissues. This evidence concerns the gene PTGS2 and breast carcinoma.